𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic studies of DISIDA disposition

✍ Scribed by James E. Love; Phillip Shaffer; Ian A. Fraser; Alfred E. Staubus; John A. Lott; George Hinkle; Larry C. Carey; E. Christopher Ellison; Peter J. Fabri


Publisher
Springer
Year
1988
Tongue
English
Weight
460 KB
Volume
14
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

✦ Synopsis


The whole blood pharmacokinetics of intravenously administered 99mTc-disofenin (DISIDA) has been studied in normal subjects and patients with documented liver disease. The apparent overall whole blood disposition rates of radioactivity were calculated from serial blood data, in order to evaluate liver clearance of DISIDA. The measurements obtained clearly discriminated 9 normal subjects from 7 patients with severe liver disease causing jaundice--1233 mls/min vs 384 mls/min (P less than 0.002). Nine subjects with liver disease of insufficient severity to cause jaundice also had clearly abnormal DISIDA disposition--642 ml/min (P less than 0.05 for difference to controls). The time activity curves from all subjects showed biexponential elimination of blood activity, with a rapid (T1/2 = 3.8 min) and a slow disposition phase (T1/2 = 75 min) in normals. These curves were fitted by computer to the timed rate of hepatic uptake, simultaneously obtained by gamma imaging over the liver. It was not possible to satisfactorily fit these using a model which assumed distribution of a single compound within two body compartments. However, another which assumed the administration of two radioactive agents satisfactorily fitted the two types of data. This conclusion is consistent with our animal experiments which indicate the existence of two compounds in injected DISIDA with contrasting high and low hepatic extraction efficiency (Fraser et al. 1988). A pharmacokinetic approach to DISIDA disposition can yield quantitative information which discriminates different degrees of liver dysfunction, but the mechanisms involved are more complicated than previously thought, so that further study should permit very precise quantification.


πŸ“œ SIMILAR VOLUMES


Pharmacokinetic studies of DISIDA dispos
✍ Ian A. Fraser; Phillip Shaffer; James Love; Alfred E. Staubus; George Hinkle; Jo πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 552 KB

The whole blood pharmacokinetics of intravenously administered 99mTc-disofenin (DISIDA) have been studied in dogs. Serial blood sampling permitted calculation of whole blood disposition rates, which principally represent liver clearance. There were striking differences in these rates between 6 norma

Disposition pharmacokinetics of bezafibr
✍ U. Abshagen; W. Bablok; K. Koch; P. D. Lang; H. A. E. Schmidt; M. Senn; H. Stork πŸ“‚ Article πŸ“… 1979 πŸ› Springer 🌐 English βš– 955 KB
Nonlinearities in amoxycillin pharmacoki
✍ F. Torres-Molina; J. E. Peris-Ribera; M. C. GarcΓ­a-Carbonell; J. C. Aristorena; πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 755 KB

Several features of amoxycillin pharmacokinetics in man are not well known in spite of the extensive clinical use of the antibiotic. In this paper it is demonstrated that amoxycillin disposition kinetics in rats is clearly nonlinear, and that this may be due mainly to its elimination mechanisms. At

Prediction of pharmacokinetics prior to
✍ Patrick Poulin; Frank-Peter Theil πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

Many in vitro data on physicochemical properties and specific absorption, distribution, metabolism, and elimination (ADME) processes are already available at early stages of drug discovery. These data about new drug candidates could be integrated/ connected in physiologically based pharmacokinetic (

Pharmacokinetics and tissue disposition
✍ Quintin A. McKellar; Ian F. Gibson; Robert Z. McCormack πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 2 views

The plasma pharmacokinetics of danofloxacin administered at 1.25 mg kg -1 body weight by the intravenous and intramuscular routes were determined in sheep. Tissue distribution was also determined following administration by the intramuscular route at 1.25 mg kg -1 body weight. Danofloxacin had a lar